Grant Boldt is currently the Chief Operating Officer at CPTx, where they lead innovation-driven R&D initiatives and oversee the integration of scientific strategy and execution in next-generation genetic medicines. Previously, Grant served in prominent roles, including Senior Vice President at Lonza and Executive Vice President at Avantor, and held positions at Sigma-Aldrich and Bachem. They earned a Bachelor of Science in Chemistry from San Diego State University, a Master of Arts in Chemistry from the same institution, and a PhD in Chemical Biology from Scripps Research. Grant is dedicated to transforming innovative ideas into practical solutions that advance organizational goals and industry standards.
This person is not in the org chart
This person is not in any teams
This person is not in any offices